GREAT Eastern on Tuesday (Feb 25) pointed to provisions made for its medical insurance business as the primary reason its net ...

Sonoma State University geology students crowd into Seawolf Plaza, Thursday, Jan. 30, 2025 during a virtual town hall meeting ...

Skin cancer is the most common form of cancer worldwide, and an estimated 1 in 5 Americans develop it by age 70, the Skin ...

A key rival to the CX-80 is the latest-generation Hyundai Sante Fe. It, too is offered in petrol and hybrid guises, with ...

Security cameras can give you peace of mind by watching things when you’re out of the house. They can also help keep tabs on ...

Gallup, in a study with Telescope, revealed that nearly all Americans use at least one AI-enabled product weekly. The study also disclosed that two-thirds (64%) of Americans don’t realize that they ...

A sparkling tennis bracelet, floor-to-ceiling velvet curtains, and 48 other products that'll add a *rich* touch to your day — ...

Some Gen Z foodpreneurs are trying to prove they are no “strawberries” and have the mettle to survive the cut-throat world of ...

A look at 2025 fantasy baseball draft strategy to help you prep for fantasy baseball drafts for the new season.

The maximum projection for POL price is $3.60, with an average price of $3.11 for the year ... Please keep in mind that each investment comes with a degree of risk. Make the most of what you've got ...

Weiss Ratings reaffirmed their sell (e+) rating on shares of 60 Degrees Pharmaceuticals (NASDAQ:SXTP – Free Report) in a research report sent to investors on Wednesday,Weiss Ratings reports.

60 Degrees Pharmaceuticals, Inc., founded in 2010, specializes in developing and marketing new medicines for the treatment and prevention of infectious diseases that affect the lives of millions ...